Erythropoietin in diabetic retinopathy. (Q47806649)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28652140 AND SRC:MED&resulttype=core&format=json

23 March 2020

review article

1 reference

title

Erythropoietin in diabetic retinopathy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28652140 AND SRC:MED&resulttype=core&format=json

23 March 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28652140 AND SRC:MED&resulttype=core&format=json

23 March 2020

author name string

Noemi Lois

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28652140 AND SRC:MED&resulttype=core&format=json

23 March 2020

publication date

8 August 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28652140 AND SRC:MED&resulttype=core&format=json

23 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28652140 AND SRC:MED&resulttype=core&format=json

23 March 2020

volume

139

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28652140 AND SRC:MED&resulttype=core&format=json

23 March 2020

page(s)

237-242

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28652140 AND SRC:MED&resulttype=core&format=json

Association between erythropoietin gene polymorphisms and diabetic retinopathy

23 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1016/J.VISRES.2017.05.010

Erythropoietin receptor mRNA expression in human endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VISRES.2017.05.010

Isolation of putative progenitor endothelial cells for angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VISRES.2017.05.010

Co-localization of erythropoietin mRNA and ecto-5'-nucleotidase immunoreactivity in peritubular cells of rat renal cortex indicates that fibroblasts produce erythropoietin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VISRES.2017.05.010

Erythropoietin--an endogenous retinal survival factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VISRES.2017.05.010

The therapeutic potential of erythropoiesis-stimulating agents for tissue protection: a tale of two receptors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VISRES.2017.05.010

Emerging biological roles for erythropoietin in the nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VISRES.2017.05.010

Erythropoietin-mediated tissue protection: reducing collateral damage from the primary injury response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VISRES.2017.05.010

Erythropoietin mediates tissue protection through an erythropoietin and common beta-subunit heteroreceptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VISRES.2017.05.010

Nonerythropoietic, tissue-protective peptides derived from the tertiary structure of erythropoietin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VISRES.2017.05.010

Müller cells in the healthy and diseased retina

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VISRES.2017.05.010

Flipping the molecular switch for innate protection and repair of tissues: Long-lasting effects of a non-erythropoietic small peptide engineered from erythropoietin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VISRES.2017.05.010

Efficacy and safety of epoetin alfa in critically ill patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VISRES.2017.05.010

Characterization of recombinant human erythropoietin produced in Chinese hamster ovary cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VISRES.2017.05.010

Anti-Epo receptor antibodies do not predict Epo receptor expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VISRES.2017.05.010

Progress in detecting cell-surface protein receptors: the erythropoietin receptor example

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VISRES.2017.05.010

Erythropoietin protects retinal pigment epithelial cells against the increase of permeability induced by diabetic conditions: essential role of JAK2/ PI3K signaling.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VISRES.2017.05.010

Expression of erythropoietin and its receptor in the human retina: a comparative study of diabetic and nondiabetic subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VISRES.2017.05.010

Erythropoietin exerts a neuroprotective function against glutamate neurotoxicity in experimental diabetic retina

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VISRES.2017.05.010

The role of Müller cells in fibrocontractive retinal disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VISRES.2017.05.010

The functional interplay between the HIF pathway and the ubiquitin system - more than a one-way road.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VISRES.2017.05.010

ARA290, a Specific Agonist of Erythropoietin/CD131 Heteroreceptor, Improves Circulating Endothelial Progenitors' Angiogenic Potential and Homing Ability.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VISRES.2017.05.010

Erythropoietin is expressed in the human retina and it is highly elevated in the vitreous fluid of patients with diabetic macular edema

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VISRES.2017.05.010

Accumulation of NH2-terminal fragment of connective tissue growth factor in the vitreous of patients with proliferative diabetic retinopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VISRES.2017.05.010

The association of previously reported polymorphisms for microvascular complications in a meta-analysis of diabetic retinopathy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VISRES.2017.05.010

Elevated erythropoietin in vitreous with ischemic retinal diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VISRES.2017.05.010

Isolation and characterization of genomic and cDNA clones of human erythropoietin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VISRES.2017.05.010

Regulation of erythropoietin production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VISRES.2017.05.010

A central role for inflammation in the pathogenesis of diabetic retinopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VISRES.2017.05.010

Common Substances That May Contribute to Resistant Hypertension, and Recommendations for Limiting Their Clinical Effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VISRES.2017.05.010

Expression of erythropoietin receptor in human epiretinal membrane of proliferative diabetic retinopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VISRES.2017.05.010

Erythropoietin is highly elevated in vitreous fluid of patients with proliferative diabetic retinopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VISRES.2017.05.010

The role of CTGF in diabetic retinopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VISRES.2017.05.010

Erythropoietin inhibits osmotic swelling of retinal glial cells by Janus kinase- and extracellular signal-regulated kinases1/2-mediated release of vascular endothelial growth factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VISRES.2017.05.010

Effects of intravitreal erythropoietin therapy for patients with chronic and progressive diabetic macular edema

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VISRES.2017.05.010

Cloning and expression of the human erythropoietin gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VISRES.2017.05.010

Endothelial progenitor cells in diabetic retinopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VISRES.2017.05.010

Epo inhibits the fibrosis and migration of Müller glial cells induced by TGF-β and high glucose

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VISRES.2017.05.010

Hypoxia-inducible factor-1 (HIF-1) promotes its degradation by induction of HIF-alpha-prolyl-4-hydroxylases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VISRES.2017.05.010

Identification of the renal erythropoietin-producing cells using transgenic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VISRES.2017.05.010

Intervention with an erythropoietin-derived peptide protects against neuroglial and vascular degeneration during diabetic retinopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VISRES.2017.05.010

Intravitreal injection of erythropoietin protects against retinal vascular regression at the early stage of diabetic retinopathy in streptozotocin-induced diabetic rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VISRES.2017.05.010

Endogenous erythropoietin protects neuroretinal function in ischemic retinopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VISRES.2017.05.010

Elevated erythropoietin mRNA and protein concentrations in the developing human eye.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VISRES.2017.05.010

Effect of erythropoietin and transfusion threshold on neurological recovery after traumatic brain injury: a randomized clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VISRES.2017.05.010

Serum and intraocular concentrations of erythropoietin and vascular endothelial growth factor in patients with type 2 diabetes and proliferative retinopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VISRES.2017.05.010

Erythropoetin receptor expression in the human diabetic retina

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VISRES.2017.05.010

Revisiting the role of erythropoietin for treatment of ocular disorders.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VISRES.2017.05.010

Association of erythropoietin gene polymorphisms with retinopathy in a Chinese cohort with type 2 diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VISRES.2017.05.010

The progress in understanding and treatment of diabetic retinopathy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VISRES.2017.05.010

ARA 290, a peptide derived from the tertiary structure of erythropoietin, produces long-term relief of neuropathic pain coupled with suppression of the spinal microglia response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VISRES.2017.05.010

Promoter polymorphism of the erythropoietin gene in severe diabetic eye and kidney complications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VISRES.2017.05.010

ARA290, a non-erythropoietic EPO derivative, attenuates renal ischemia/reperfusion injury.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VISRES.2017.05.010

VEGF-mediated STAT3 activation inhibits retinal vascularization by down-regulating local erythropoietin expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VISRES.2017.05.010

Long-term Treatment with Suberythropoietic Epo is Vaso- and Neuroprotective in Experimental Diabetic Retinopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VISRES.2017.05.010

Erythropoietin as a retinal angiogenic factor in proliferative diabetic retinopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VISRES.2017.05.010

Effect of erythropoietin axotomy-induced apoptosis in rat retinal ganglion cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VISRES.2017.05.010

Erythropoietin promotes retinal angiogenesis in a mouse model.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VISRES.2017.05.010

Erythropoietin Protects Retinal Cells in Diabetic Rats Through Upregulating ZnT8 via Activating ERK Pathway and Inhibiting HIF-1α Expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VISRES.2017.05.010

Subretinal delivery of AAV2-mediated human erythropoietin gene is protective and safe in experimental diabetic retinopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VISRES.2017.05.010

VEGFA activates erythropoietin receptor and enhances VEGFR2-mediated pathological angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VISRES.2017.05.010

Intravitreal injection of erythropoietin protects both retinal vascular and neuronal cells in early diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VISRES.2017.05.010

Erythropoietin protects retinal neurons and glial cells in early-stage streptozotocin-induced diabetic rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VISRES.2017.05.010

10.1016/J.VISRES.2017.05.010

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28652140 AND SRC:MED&resulttype=core&format=json

23 March 2020

1 reference